Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes

BACKGROUND: We recently reported that short-term treatment with liraglutide (20.0 ± 6.4 days) reduced body weight and improved some scales of eating behavior in Japanese type 2 diabetes inpatients. However, it remained uncertain whether such liraglutide-induced improvement is maintained after discha...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fujishima, Yuya, Maeda, Norikazu, Inoue, Kana, Kashine, Susumu, Nishizawa, Hitoshi, Hirata, Ayumu, Kozawa, Junji, Yasuda, Tetsuyuki, Okita, Kohei, Imagawa, Akihisa, Funahashi, Tohru, Shimomura, Iichiro
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2012
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3459720/
https://ncbi.nlm.nih.gov/pubmed/22973968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-11-107
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires